|Articles|March 10, 2022
Survey: Pandemic impact on consumer trust in biopharma
Author(s)Reverba Global
The biopharma industry launched COVID vaccines and treatments in record time. How did this impact consumer trust? We asked, and compared survey results with 2017 data.
Trending on PharmExec
1
Eli Lilly and Novo Nordisk Shift Patients From Compounded Drugs to Lower-Cost Weight-Loss Pills: Report
2
FDA Approves Datroway for Patients with Metastatic Triple-Negative Breast Cancer Who Are Not PD-1/PD-L1 Inhibitor Candidates
3
The Evolving Relationship Between FDA and Biotech
4
Eli Lilly Enters $202 Million Agreement to Acquire Engage Bio
5